Stefán Jónsson joins Akthelia as Director of CMC

Icelandic biotech R&D company Akthelia Pharmaceuticals has appointed Stefán Jónsson, PhD, as Head of Chemistry, Manufacturing, and Control (CMC) and Intellectual Property. In this role, Dr. Jónsson will lead strategy and execution across development, analytical, and manufacturing processes, pharmaceutical substances and formulations, as well as the company’s intellectual property strategy.

Dr. Jónsson brings two decades of experience in analytical methodologies, proteomics, mass spectrometry, pharmaceutical formulation, and scientific leadership. He most recently served as a department head at Alvotech, where he worked in analytical R&D. Prior to that, he held positions at Actavis and deCODE genetics. In addition, Dr. Jónsson has taught organic chemistry at the University of Iceland. He holds a PhD in Organic Chemistry from Lund University and a BSc in Biochemistry from the University of Iceland.

A pivotal moment for Akthelia

“The expertise that Stefán brings in analytical technologies and manufacturing processes, and financial management strengthens Akthelia’s foundations at a key moment as the company prepares for entering the clinic” said Egill Másson, CEO of Akthelia.